NexImmune, Inc. Contracts & Agreements
33 Contracts & Agreements
- Business Finance (8 contracts)
- Business Operations (2)
- Human Resources (17)
- Intellectual Property (1)
- Real Estate (2)
- Uncategorized (3)
- Securities Purchase Agreement, dated as of February 2, 2024, by and between NexImmune, Inc. and the purchaser listed therein (Filed With SEC on February 5, 2024)
- Form of Placement Agent Warrant (Filed With SEC on February 5, 2024)
- Form of Unregistered Warrant (Filed With SEC on February 5, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on February 5, 2024)
- Consultation Agreement, by and between the Company and Jerome Zeldis, M.D., Ph.D., dated March 23, 2023 (Filed With SEC on March 28, 2023)
- First Amendment to Employment Agreement by and between the Registrant and Mathias Oelke, date August 11, 2022 (Filed With SEC on August 15, 2022)
- Controlled Equity Offering Sales AgreementSM, dated June 17, 2022, by and among NexImmune Inc., Cantor Fitzgerald & Co. and BTIG, LLC (Filed With SEC on June 17, 2022)
- Joint Research Agreement, by and between Zephyr AI, Inc. and NexImmune, Inc., dated March 16, 2022 (Filed With SEC on May 12, 2022)
- Employment Agreement, by and between the Registrant and Mathias Oelke, date April 5, 2022 (Filed With SEC on May 12, 2022)
- Employment Agreement, by and between the Company and Kristi Jones, dated (Filed With SEC on March 9, 2022)
- Separation Agreement, dated February 12, 2022 (Filed With SEC on February 17, 2022)
- Non-Employee Director Compensation Policy (Filed With SEC on May 17, 2021)
- Description of Securities (Filed With SEC on March 31, 2021)
- Employment Agreement, by and between the Registrant and Jerome Zeldis, M.D., Ph.D., dated January 4, 2021 (Filed With SEC on February 8, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on February 8, 2021)
- Employment Agreement, by and between the Registrant and Robert Knight, M.D., dated January 6, 2021 (Filed With SEC on February 8, 2021)
- Employment Agreement, by and between the Registrant and Kristi Jones, dated February 27, 2017 (Filed With SEC on February 8, 2021)
- Employment Agreement, by and between the Registrant and John Trainer, dated January 6, 2020 (Filed With SEC on February 8, 2021)
- Employment Agreement, by and between the Registrant and Scott Carmer, dated February 3, 2021 (Filed With SEC on February 8, 2021)
- Form of Stock Option Agreement under the 2021 Equity Incentive Plan (Filed With SEC on February 8, 2021)
- 2021 Equity Incentive Plan (Filed With SEC on February 8, 2021)
- Form of Stock Option Agreement under the 2018 Equity Incentive Plan, as amended (Filed With SEC on February 8, 2021)
- 2018 Equity Incentive Plan, as amended (Filed With SEC on February 8, 2021)
- Form of Stock Option Agreement under the 2017 Equity Incentive Plan, as amended (Filed With SEC on February 8, 2021)
- 2017 Equity Incentive Plan, as amended (Filed With SEC on February 8, 2021)
- Form of Indemnification Agreement (Filed With SEC on February 8, 2021)
- Second Amended and Restated Investors Rights Agreement, by and between the Registrant and the investors listed therein, dated November 27, 2019 (Filed With SEC on February 8, 2021)
- Form of Convertible Promissory Note, as amended (Filed With SEC on February 8, 2021)
- Form of Common Stock Certificate (Filed With SEC on February 8, 2021)
- Form of Underwriting Agreement (Filed With SEC on February 8, 2021)
- Amended and Restated Exclusive License Agreement, by and between the Johns Hopkins University and NexImmune, Inc., dated June 21, 2011 (Filed With SEC on January 19, 2021)
- Sublease Agreement, by and between the Company and Modavar Pharmaceuticals LLC, dated December 11, 2017 (Filed With SEC on January 19, 2021)
- Lease Agreement, by and between the Company and W. M. Rickman Construction Co., LLC, dated June 30, 2017 (Filed With SEC on January 19, 2021)
